149 related articles for article (PubMed ID: 19194551)
1. The breakdown of preformed peritoneal advanced glycation end products by intraperitoneal alagebrium.
Lee YK; Lee JY; Kim JS; Won KB; Kang HJ; Jang TJ; Tak WT; Lee JH
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S189-94. PubMed ID: 19194551
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycosylation end-products in diabetic rats on peritoneal dialysis using various solutions.
Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
Perit Dial Int; 2000; 20(6):643-51. PubMed ID: 11216553
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
[TBL] [Abstract][Full Text] [Related]
4. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
Park MS; Kim JK; Holmes C; Weiss MF
Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal infusion of glucose-based dialysate in the rat--an animal model for the study of peritoneal advanced glycation end-products formation and effect on peritoneal transport.
Zeltzer E; Klein O; Rashid G; Katz D; Korzets Z; Bernheim J
Perit Dial Int; 2000; 20(6):656-61. PubMed ID: 11216555
[TBL] [Abstract][Full Text] [Related]
6. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
7. AGE accumulation in peritoneal membrane and cavity during peritoneal dialysis and its effect on peritoneal structure and function.
Park MS; Lee HB
Perit Dial Int; 1999; 19 Suppl 2():S53-7. PubMed ID: 10406494
[No Abstract] [Full Text] [Related]
8. Structural and functional alterations of the peritoneum after prolonged exposure to dialysis solutions: role of aminoguanidine.
Lee EA; Oh JH; Lee HA; Kim SI; Park EW; Park KB; Park MS
Perit Dial Int; 2001; 21(3):245-53. PubMed ID: 11475339
[TBL] [Abstract][Full Text] [Related]
9. The effect of advanced glycation end-products and aminoguanidine on TNFalpha production by rat peritoneal macrophages.
Rashid G; Luzon AA; Korzets Z; Klein O; Zeltzer E; Bernheim J
Perit Dial Int; 2001; 21(2):122-9. PubMed ID: 11330554
[TBL] [Abstract][Full Text] [Related]
10. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal transport in long-term peritoneal dialysis patients and its relation with AGEs.
Feriani M
Contrib Nephrol; 2001; (131):74-81. PubMed ID: 11125565
[No Abstract] [Full Text] [Related]
12. Effects of peritoneal rest on peritoneal transport and peritoneal membrane thickening in continuous ambulatory peritoneal dialysis rats.
Kim YL; Kim SH; Kim JH; Kim SJ; Kim CD; Cho DK; Kim YJ; Moberly JB
Perit Dial Int; 1999; 19 Suppl 2():S384-7. PubMed ID: 10406551
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products are associated with immature angiogenesis and peritoneal dysfunction in patients on peritoneal dialysis.
Nakano T; Mizumasa T; Kuroki Y; Eriguchi M; Yoshida H; Taniguchi M; Masutani K; Tsuruya K; Kitazono T
Perit Dial Int; 2020 Jan; 40(1):67-75. PubMed ID: 32063152
[TBL] [Abstract][Full Text] [Related]
14. The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment.
Usta MF; Kendirci M; Gur S; Foxwell NA; Bivalacqua TJ; Cellek S; Hellstrom WJ
J Sex Med; 2006 Mar; 3(2):242-50; discussion 250-2. PubMed ID: 16490017
[TBL] [Abstract][Full Text] [Related]
15. Chronic peritoneal dialysis in iron-deficient rats with solutions containing iron dextran.
Reddy DK; Moore HL; Lee JH; Saran R; Nolph KD; Khanna R; Twardowski ZJ
Kidney Int; 2001 Feb; 59(2):764-73. PubMed ID: 11168960
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of taurine as an osmotic agent for peritoneal dialysis solution.
Nishimura H; Ikehara O; Naito T; Higuchi C; Sanaka T
Perit Dial Int; 2009; 29(2):204-16. PubMed ID: 19293359
[TBL] [Abstract][Full Text] [Related]
17. 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids infused into the peritoneal cavity cannot be found in plasma.
Erixon M; Wieslander A; Lindén T; Carlsson O; Jönsson JA; Simonsen O; Kjellstrand P
Perit Dial Int; 2009 Feb; 29 Suppl 2():S28-31. PubMed ID: 19270226
[TBL] [Abstract][Full Text] [Related]
18. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
[TBL] [Abstract][Full Text] [Related]
19. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
[TBL] [Abstract][Full Text] [Related]
20. Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.
Kihm LP; Müller-Krebs S; Klein J; Ehrlich G; Mertes L; Gross ML; Adaikalakoteswari A; Thornalley PJ; Hammes HP; Nawroth PP; Zeier M; Schwenger V
J Am Soc Nephrol; 2011 May; 22(5):914-26. PubMed ID: 21511829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
